Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Dimic-Janjic, Sanja (58019271900)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Diagnosis and treatment of adult asthma patients in Serbia: a 2022 experts group position statement
    (2022)
    Vukoja, Marija (57216932269)
    ;
    Kopitovic, Ivan (36056890700)
    ;
    Lazic, Zorica (24830912400)
    ;
    Milenkovic, Branislava (23005307400)
    ;
    Stankovic, Ivana (13604993500)
    ;
    Tomic-Spiric, Vesna (6603500319)
    ;
    Zvezdin, Biljana (32868275200)
    ;
    Hromis, Sanja (32867618500)
    ;
    Cekerevac, Ivan (24830194100)
    ;
    Ilic, Aleksandra (7004055911)
    ;
    Vukcevic, Miodrag (6602095465)
    ;
    Dimic-Janjic, Sanja (58019271900)
    ;
    Stjepanovic, Mihailo (55052044500)
    Introduction: Asthma is the most common non-communicable chronic lung condition across all ages. Epidemiological data indicate that many asthma patients in Serbia remain undiagnosed and untreated. The implementation of recent global advances in asthma management is limited due to the lack of a systematic approach, drug availability and regulatory affairs. In addition, the global coronavirus disease pandemic has posed a significant challenge, particularly in resource-limited settings. Areas covered: In this paper, we propose an algorithm for treating adult asthma patients in Serbia. We performed PubMed database search on published asthma clinical trials and guidelines from 1 January 2015 to 10 March 2020. The consensus process incorporated a modified Delphi method that included two rounds of e-mail questionnaires and three rounds of national asthma expert meetings. We focus on 1) objective diagnosis of asthma, 2) the implementation of up-to-date therapeutic options, and 3) the identification and referral of severe asthma patients to newly established severe asthma centers. Expert opinion: Regional specificities and variations in healthcare systems require the adaptation of evidence-based knowledge. Practical, clinically oriented algorithms designed to overcome local barriers in healthcare delivery may facilitate timely and adequate asthma diagnosis and the local implementation of current advances in asthma management. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Utility of neutrophil to lymphocyte ratio in the prediction of inflammation and COPD mortality
    (2025)
    Dimic-Janjic, Sanja (58019271900)
    ;
    Zecevic, Andrej (58846253100)
    ;
    Golubovic, Aleksa (58258139500)
    ;
    Ratkovic, Ana (58541092000)
    ;
    Milivojevic, Ivan (58150217900)
    ;
    Postic, Anka (59926371000)
    ;
    Stjepanovic, Mihailo (55052044500)
    ;
    Jankovic, Jelena (57211575577)
    ;
    Trboljevac, Nikola (57722831100)
    ;
    Barac, Aleksandra (55550748700)
    ;
    Popevic, Spasoje (54420874900)
    ;
    Samardzic, Ana (57208631860)
    ;
    Isovic, Lidija (59927041800)
    ;
    Milenkovic, Branislava (23005307400)
    Introduction: The Neutrophil-to-Lymphocyte Ratio (NLR) has been utilized to predict clinical outcomes in cardiovascular diseases, infectious diseases, and solid tumors and it has a potential association with the severity of Chronic Obstructive Pulmonary Disease (COPD). This study aimed to determine whether NLR is a possible predictor of inflammation severity and mortality in COPD. Methodology: A prospective analysis of NLR in 70 COPD patients, and its relation with biochemical, lung function parameters, and mortality was assessed. Results: NLR was negatively associated with oxygen saturation (p < 0.05) and positively related to C-reactive protein (CRP) (p < 0.05), matrix metalloproteinase-9 (MMP-9) (p ≤ 0.001), tissue inhibitor of metalloproteinase-1 (TIMP-1) (p < 0.05), MMP-9/TIMP-1 ratio (p < 0.05), and the modified Medical Research Council dyspnea scale (mMRC) score (p < 0.05). Deceased patients had significantly higher NLR (p < 0.05). Older age and lower levels of saturation were independently associated with higher mortality in COPD patients (p < 0.05). Conclusions: NLR in COPD correlates with inflammation and protease/antiprotease balance, with elevated NLR detected in deceased patients. These findings suggest that NLR can be a helpful clinical marker in COPD. Copyright © 2025 Dimic-Janjic et al.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback